Nexentis Technologies Inc. Common Stock

NXTS XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

2.6M

Short interest (Jul 15)

1.9%

Net Short (Jul 27 ): -0.2%

Borrow Fee

24.12%

↓ 31.4%

Available Shares

200K

↑ 51.3%

Price Chart

Company Overview

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001789192

Asset Type: CS

Market Data

Market Cap: $2,615,999

Employees: 9

Status: Active

Short Interest

Current Borrow Fee 24.12%

Range: 24.12% - 24.12%

Available Shares 200K

Range: 100K - 150K

Recent Changes

Fee Change: ↓ 0.3%

Available Change: ↓ 0.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime